Nuzenio

Fgfr

Fgfr news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

China approves therapy tackling FGFR inhibitor resistance in biliary cancer - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 13:02:10 GMTYochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - europeanpharmaceuticalreview.comeuropeanpharmaceuticalreview.com · Fri, 07 Aug 2026 12:25:36 GMTTransThera's resistant biliary cancer drug cleared in China - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 11:50:30 GMTYochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 06:44:00 GMTTransThera wins first China approval in post-FGFR cholangiocarcinoma - AllSciAllSci · Thu, 06 Aug 2026 16:41:13 GMTSequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma - oncodaily.comoncodaily.com · Thu, 06 Aug 2026 14:43:41 GMT

Timeline

Fri, 07 Aug 2026 13:02:10 GMTChina approves therapy tackling FGFR inhibitor resistance in biliary cancer - FirstWord Pharma
Fri, 07 Aug 2026 12:25:36 GMTYochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - europeanpharmaceuticalreview.com
Fri, 07 Aug 2026 11:50:30 GMTTransThera's resistant biliary cancer drug cleared in China - pharmaphorum
Fri, 07 Aug 2026 06:44:00 GMTYochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China - Yahoo Finance Australia
Thu, 06 Aug 2026 16:41:13 GMTTransThera wins first China approval in post-FGFR cholangiocarcinoma - AllSci
Thu, 06 Aug 2026 14:43:41 GMTSequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma - oncodaily.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fgfr.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.